SXR3:XETRA:XETRA-iShares VII PLC - iShares MSCI UK ETF GBP Acc (EUR)

ETF | Others |

Last Closing

USD 173.26

Change

+0.64 (+0.37)%

Market Cap

USD 0.10B

Volume

62.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.68 (+1.34%)

USD 473.61B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.21 (+1.26%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.35 (+1.31%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.36 (+1.29%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.32 (+1.35%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+0.14 (+0.08%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.47 (+1.05%)

USD 101.50B
8R80:XETRA Amundi Index Solutions - Amund..

+0.88 (+0.61%)

USD 99.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.67 (+1.32%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.40 (+0.46%)

USD 80.38B

ETFs Containing SXR3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.20% 79% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.20% 79% B- 77% C+
Trailing 12 Months  
Capital Gain 14.33% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.33% 57% F 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.81% 71% C- 68% D+
Dividend Return 8.81% 70% C- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.20% 61% D- 69% C-
Risk Adjusted Return 86.34% 95% A 94% A
Market Capitalization 0.10B 34% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.